Destée A - Search Results

1

Bordet R, Destée A. Bordet R, et al. Among authors: destee a. Rev Neurol (Paris). 1992;148(1):62-3. Rev Neurol (Paris). 1992. PMID: 1604117 French.

2

[Hashimoto's encephalopathy: toxic or autoimmune mechanism?].

Ghawche F, Bordet R, Destée A. Ghawche F, et al. Among authors: destee a. Rev Neurol (Paris). 1992;148(5):371-3. Rev Neurol (Paris). 1992. PMID: 1448653 French.

3

[Epidural angiolipoma and multiple familial lipomatosis].

Bordet R, Ghawche F, Destée A. Bordet R, et al. Among authors: destee a. Rev Neurol (Paris). 1991;147(11):740-2. Rev Neurol (Paris). 1991. PMID: 1775830 Review. French.

4

[From Parkinson's disease to Lewy body disease].

Bordet R, Destée A. Bordet R, et al. Among authors: destee a. Presse Med. 1992 Apr 18;21(15):708-12. Presse Med. 1992. PMID: 1534893 Review. French.

5

[Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases].

Vermersch P, Bordet R, Ledoze F, Ruchoux MM, Chapon F, Thomas P, Destée A, Lechevallier B, Delacourte A. Vermersch P, et al. Among authors: destee a. C R Acad Sci III. 1995 Apr;318(4):439-45. C R Acad Sci III. 1995. PMID: 7648357 French.

6

[Progressive muscular dystrophies and drug risks].

Bordet R, Caron J, Destée A, Dupuis B. Bordet R, et al. Among authors: destee a. Therapie. 1994 Mar-Apr;49(2):129-32. Therapie. 1994. PMID: 7817336 Review. French.

7

[Acute catatonia and neuroleptic malignant syndrome. A case of infantile psychosis].

Revuelta E, Bordet R, Piquet T, Ghawche F, Destee A, Goudemand M. Revuelta E, et al. Among authors: destee a. Encephale. 1994 May-Jun;20(3):351-4. Encephale. 1994. PMID: 7916282 French.

8

Vigilance states in a parkinsonian model, the MPTP mouse.

Monaca C, Laloux C, Jacquesson JM, Gelé P, Maréchal X, Bordet R, Destée A, Derambure P. Monaca C, et al. Among authors: destee a. Eur J Neurosci. 2004 Nov;20(9):2474-8. doi: 10.1111/j.1460-9568.2004.03694.x. Eur J Neurosci. 2004. PMID: 15525288

9

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D; Parkgait-II study group. Moreau C, et al. Among authors: destee a. Lancet Neurol. 2012 Jul;11(7):589-96. doi: 10.1016/S1474-4422(12)70106-0. Epub 2012 Jun 1. Lancet Neurol. 2012. PMID: 22658702 Clinical Trial.

10

Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.

Kreisler A, Gelé P, Wiart JF, Lhermitte M, Destée A, Bordet R. Kreisler A, et al. Among authors: destee a. Brain Res. 2007 Mar 2;1135(1):77-84. doi: 10.1016/j.brainres.2006.12.011. Epub 2007 Jan 2. Brain Res. 2007. PMID: 17196944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters